A Systematic Review and Economic Evaluation of Prasugrel Compared to Clopidogrel After PCI [Internet].

A systematic review and economic evaluation of prasugrel compared to clopidogrel after PCI Patients who have undergone percutaneous coronary intervention (PCI) for coronary artery disease usually get a platelet inhibitor (e.g. clopidogrel) for one year after the procedure. Prasugrel is a new platelet inhibitor which is available for patients with acute coronary syndrome (ACS) who undergo PCI in Norway.

http://ift.tt/2pZYEY4